Hong‐Xi Xu

20.3k total citations · 1 hit paper
548 papers, 16.2k citations indexed

About

Hong‐Xi Xu is a scholar working on Molecular Biology, Plant Science and Pharmacology. According to data from OpenAlex, Hong‐Xi Xu has authored 548 papers receiving a total of 16.2k indexed citations (citations by other indexed papers that have themselves been cited), including 276 papers in Molecular Biology, 160 papers in Plant Science and 102 papers in Pharmacology. Recurrent topics in Hong‐Xi Xu's work include Natural Compound Pharmacology Studies (92 papers), Natural product bioactivities and synthesis (68 papers) and Phytochemistry and Biological Activities (51 papers). Hong‐Xi Xu is often cited by papers focused on Natural Compound Pharmacology Studies (92 papers), Natural product bioactivities and synthesis (68 papers) and Phytochemistry and Biological Activities (51 papers). Hong‐Xi Xu collaborates with scholars based in China, Hong Kong and United States. Hong‐Xi Xu's co-authors include Quan‐Bin Han, Chun‐Feng Qiao, Jing‐Zheng Song, Shilin Chen, Paul Pui‐Hay But, Song F. Lee, Hongsheng Tan, Zhaoxiang Bian, Jingyuan Song and Wenwei Fu and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Hong‐Xi Xu

526 papers receiving 15.7k citations

Hit Papers

Use of ITS2 Region as the... 2010 2026 2015 2020 2010 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hong‐Xi Xu China 63 8.3k 4.4k 2.6k 2.5k 2.5k 548 16.2k
Wen‐Cai Ye China 55 8.3k 1.0× 3.8k 0.9× 2.7k 1.1× 2.3k 0.9× 1.5k 0.6× 718 16.1k
Jin‐Ao Duan China 59 7.6k 0.9× 3.3k 0.8× 2.6k 1.0× 2.0k 0.8× 3.5k 1.4× 707 15.0k
Jing‐Gung Chung Taiwan 69 10.4k 1.3× 3.5k 0.8× 2.1k 0.8× 3.2k 1.3× 1.4k 0.6× 550 18.8k
Yeong Shik Kim South Korea 64 6.6k 0.8× 2.4k 0.6× 2.2k 0.9× 1.7k 0.7× 1.6k 0.7× 299 13.1k
Anupam Bishayee United States 79 9.5k 1.1× 2.7k 0.6× 2.0k 0.8× 1.8k 0.7× 1.6k 0.7× 312 20.2k
Kyung‐Tae Lee South Korea 63 6.8k 0.8× 2.7k 0.6× 1.8k 0.7× 2.0k 0.8× 1.5k 0.6× 495 14.2k
Gow‐Chin Yen Taiwan 83 7.7k 0.9× 6.2k 1.4× 3.2k 1.2× 2.4k 0.9× 2.1k 0.9× 317 23.9k
Richard B. van Breemen United States 70 7.4k 0.9× 2.1k 0.5× 2.9k 1.1× 1.2k 0.5× 1.2k 0.5× 404 16.6k
Ikhlas A. Khan United States 67 8.6k 1.0× 7.6k 1.8× 3.6k 1.4× 4.1k 1.6× 3.7k 1.5× 916 23.4k
Ping Li China 63 9.4k 1.1× 3.3k 0.8× 3.2k 1.2× 1.6k 0.6× 4.3k 1.8× 672 17.2k

Countries citing papers authored by Hong‐Xi Xu

Since Specialization
Citations

This map shows the geographic impact of Hong‐Xi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hong‐Xi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hong‐Xi Xu more than expected).

Fields of papers citing papers by Hong‐Xi Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hong‐Xi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hong‐Xi Xu. The network helps show where Hong‐Xi Xu may publish in the future.

Co-authorship network of co-authors of Hong‐Xi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Hong‐Xi Xu. A scholar is included among the top collaborators of Hong‐Xi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hong‐Xi Xu. Hong‐Xi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Yin, et al.. (2025). Asperuloside suppresses the progression of depression through O-GlcNAcylation of IκBα and regulating NFκB signaling. Journal of Pharmacological Sciences. 157(3). 179–188. 1 indexed citations
3.
Zhang, Huimin, Yefeng Tang, Hong‐Xi Xu, Shungui Zhou, & Tao Zhang. (2025). Research on expression patterns of endogenous OASL and IFN-α in duck embryos infected with DHAV-3. Polish Journal of Veterinary Sciences. 28(1). 25–33.
4.
Dai, Rongchen, et al.. (2024). Repurposing cardiac glycosides for anticancer treatment: a review of clinical studies. Drug Discovery Today. 29(10). 104129–104129. 4 indexed citations
5.
Wang, Youyi, Huimin Zheng, Xue Jiang, et al.. (2024). Caged xanthone derivatives to promote mitochondria-mediated apoptosis in breast cancer cells. Bioorganic & Medicinal Chemistry. 103. 117655–117655. 1 indexed citations
6.
Zhang, Qilong, Zhou Xu, Xiaofeng Shan, et al.. (2024). 2-Hydroxynaphthalenyl hemicarbocyanine dyes: Hypochlorite response and UV-catalysed induction of the formation of chlorinated hemicarbocyanine-like naphtho[2,1-b]furans. Sensors and Actuators B Chemical. 426. 137105–137105. 3 indexed citations
8.
Zhang, Juan, Yulin Wu, Hong‐Xi Xu, et al.. (2024). Brusatol alleviates pancreatic carcinogenesis via targeting NLRP3 in transgenic Krastm4Tyj Trp53tm1Brn Tg (Pdx1-cre/Esr1*) #Dam mice. Biomedicine & Pharmacotherapy. 177. 116977–116977. 2 indexed citations
10.
Li, Chunlin, Li Zhang, Yanqi Dang, et al.. (2021). Jiangzhi Granule attenuates non-alcoholic steatohepatitis by suppressing TNF/NFκB signaling pathway-a study based on network pharmacology. Biomedicine & Pharmacotherapy. 143. 112181–112181. 25 indexed citations
11.
Shen, Kaikai, Jianling Xie, Hua Wang, et al.. (2015). Cambogin Induces Caspase-Independent Apoptosis through the ROS/JNK Pathway and Epigenetic Regulation in Breast Cancer Cells. Molecular Cancer Therapeutics. 14(7). 1738–1749. 37 indexed citations
12.
Feng, Chao, Sheng‐Xiong Huang, Xuemei Gao, Hong‐Xi Xu, & Kathy Qian Luo. (2014). Characterization of Proapoptotic Compounds from the Bark of Garcinia oblongifolia. Journal of Natural Products. 77(5). 1111–1116. 17 indexed citations
13.
Xu, Hong‐Xi. (2013). Antioxidant and Anti-browning Activities of Ethanol Extract from Lotus Seed Skin. Food Science. 1 indexed citations
14.
Wang, Chang, et al.. (2012). Trimethylamine oxide in diets for taimen (Hucho taimen): effects on growth performance, muscle composition, gastrointestinal lipase activity and serum biochemical indices.. Dongwu yingyang xuebao. 24(11). 2279–2286. 5 indexed citations
16.
Feng, Chao, Ting Yu, Gang Xu, et al.. (2011). A new anticancer compound, Oblongifolin C, inhibits tumor growth and promotes apoptosis in HeLa cells through bax activation. International Journal of Cancer. 131(6). 1445–1454. 50 indexed citations
17.
Millikan, Mary B., et al.. (2011). Metal Analysis of Si Wu Tang in Relation to its Clinical Application. Victoria University Research Repository (Victoria University). 1 indexed citations
18.
Yao, Hui, Jingyuan Song, Chang Liu, et al.. (2010). Use of ITS2 Region as the Universal DNA Barcode for Plants and Animals. PLoS ONE. 5(10). e13102–e13102. 691 indexed citations breakdown →
19.
Chen, Shu‐Ling, et al.. (2006). Regulatory effect of puerarin on lipid profile in hypercholesterolemic rats. PolyU Institutional Research Archive (Hong Kong Polytechnic University). 1 indexed citations
20.
Xu, Hong‐Xi, et al.. (2006). Antiviral and Immunomodulatory Properties of Prunella vulgaris. 亚洲传统医药. 1(1). 45–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026